山东新华制药股份(00719)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00719 山东新华制药股份

交易中 04-23 13:03:35

5.570

+0.010

+0.18%

最高5.610	最低5.560	成交量71.26万
今开5.570	昨收5.560	日振幅0.90%
总市值38.43亿	流通市值10.86亿	总股本6.90亿
成交额397.97万	换手率0.37%	流通股本1.95亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":5.57,"timestamp":1745384543202,"preClose":5.56,"halted":0,"volume":712600,"delay":0,"floatShares":195000000,"shares":690000000,"eps":0.7325198592277076,"marketStatus":"交易中","change":0.01,"latestTime":"04-23 13:03:35","open":5.57,"high":5.61,"low":5.56,"amount":3979684,"amplitude":0.008993,"askPrice":5.6,"askSize":76000,"bidPrice":5.57,"bidSize":34000,"shortable":0,"etf":0,"ttmEps":0.7228758310173871,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745395800000},"marketStatusCode":2,"adr":0,"listingDate":851961600000,"exchange":"SEHK","adjPreClose":5.56,"dividendRate":0.052405,"openAndCloseTimeList":[[1745371800000,1745380800000],[1745384400000,1745395200000]],"volumeRatio":1.045776,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":14.15,"timestamp":1745384610000,"preClose":14.25,"halted":0,"volume":3667100,"delay":0,"premium":"-62.97"}},"requestUrl":"/m/hq/s/00719","defaultTab":"news","newsList":[{"id":"2527618381","title":"山东新华制药股份(00719)收到国家药品监督管理局核准签发的艾司唑仑片(1mg、2mg)《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2527618381","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527618381?lang=zh_cn&edition=full","pubTime":"2025-04-14 16:53","pubTimestamp":1744620829,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，近日，该公司收到国家药品监督管理局核准签发的艾司唑仑片(1mg、2mg)(以下简称“本品”)《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。艾司唑仑片(1mg、2mg)于2025年4月通过国家药品监督管理局审批，新华制药成为本品的上市许可持有人。该产品的上市，有利于丰富公司精麻药品系列产品线，提升公司综合竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)收到国家药品监督管理局核准签发的艾司唑仑片(1mg、2mg)《药品补充申请批准通知书》","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1191","00719"],"gpt_icon":0},{"id":"2527186477","title":"山东新华制药股份(00719)氨茶碱片通过药监局仿制药质量和疗效一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2527186477","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527186477?lang=zh_cn&edition=full","pubTime":"2025-04-14 16:49","pubTimestamp":1744620577,"startTime":"0","endTime":"0","summary":"金吾财讯 | 山东新华制药股份(00719)公布，公司收到国家药品监督管理局核准签发的氨茶碱片(《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价。本品对呼吸道平滑肌有直接松弛作用，适用于支气管哮喘、喘息型支气管炎、阻塞性肺气肿等缓解喘息症状；也可用于心源性肺水肿引起的哮喘。氨茶碱片属于《国家基本药物目录》与《国家基本医疗保险、工伤保险和生育保险药品目录(2023年)》甲类品种，根据有关统计数据显示，2023年中国公立医疗机构氨茶碱销售额约为人民币6.51亿元。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/MTczNjE1NTkxMzE1OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/MTczNjE1NTkxMzE1OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957172","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00719","BK1515"],"gpt_icon":0},{"id":"2527907229","title":"山东新华制药股份(00719)：氨茶碱片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2527907229","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527907229?lang=zh_cn&edition=full","pubTime":"2025-04-14 16:32","pubTimestamp":1744619579,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，近日，山东新华制药股份有限公司(以下简称“新华制药”或“本公司”)收到国家药品监督管理局核准签发的氨茶碱片(以下简称“本品”)《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00719","BK1515"],"gpt_icon":0},{"id":"2527911729","title":"新华制药3709.2万股限售股将于4月14日解禁，占总股本5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527911729","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527911729?lang=zh_cn&edition=full","pubTime":"2025-04-14 08:09","pubTimestamp":1744589352,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，新华制药于4月14日将有3709.2万股限售股份解禁，为公司定向增发机构配售股份，占公司总股本5.38%。本次解禁后，公司还有215.26万股限售股份，占总股本0.31%。新华制药主营业务：开发、制造和销售化学原料药、制剂、医药中间体及其他产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414081542a457dc2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414081542a457dc2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00719","BK1515"],"gpt_icon":0},{"id":"2517995807","title":"山东新华制药股份03月05日主力净流入61万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517995807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517995807?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:16","pubTimestamp":1741162580,"startTime":"0","endTime":"0","summary":"03月05日, 山东新华制药股份股价涨0.53%，报收5.69元，成交金额818万元，换手率0.74%，振幅1.24%，量比0.62。山东新华制药股份今日主力资金净流入61万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.07%，主力资金累计净流出2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出203万元，其中净流出天数为6日。该股主力净额占比0.06%，港股市场排名165/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170305a2605a7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170305a2605a7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","00719"],"gpt_icon":0},{"id":"2516500055","title":"新华制药获批成为“硫酸氢氯吡格雷片 ”上市许可持有人","url":"https://stock-news.laohu8.com/highlight/detail?id=2516500055","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516500055?lang=zh_cn&edition=full","pubTime":"2025-03-03 16:44","pubTimestamp":1740991464,"startTime":"0","endTime":"0","summary":"新华制药发布公告，近日，公司收到国家药品监督管理局核准签发的硫酸氢氯吡格雷片《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。据悉，硫酸氢氯吡格雷片为循环系统疾病药物，系一种前体药物，其代谢产物之一是血小板聚集抑制剂。硫酸氢氯吡格雷片于2025年2月通过国家药品监督管理局审批，新华制药成为本品的上市许可持有人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165527a25cd460&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165527a25cd460&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00719","BK1515"],"gpt_icon":0},{"id":"2516023635","title":"山东新华制药股份(00719)收到硫酸氢氯吡格雷片《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2516023635","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516023635?lang=zh_cn&edition=full","pubTime":"2025-03-03 16:32","pubTimestamp":1740990730,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，近日，该公司收到国家药品监督管理局核准签发的硫酸氢氯吡格雷片(以下简称“本品”)《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。公告称，硫酸氢氯吡格雷片于2025年2月通过国家药品监督管理局审批，新华制药成为本品的上市许可持有人。该产品的上市，有利于丰富公司循环系统药物产品线，提升公司综合竞争优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719","BK1191","BK1515"],"gpt_icon":0},{"id":"2512419341","title":"新华制药：感谢您对公司关注与支持，感谢您的意见与建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2512419341","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512419341?lang=zh_cn&edition=full","pubTime":"2025-02-20 17:00","pubTimestamp":1740042044,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药02月20日在投资者关系平台上答复投资者关心的问题。请问董秘，如何看待AI制药领域未来的前景，以及公司未来在AI制药领域的战略布局？业内传闻同属山东国资委旗下的新华制药和鲁抗医药正在谋划国资并购重组，请问董秘方便透露目前的最新进展吗？巨潮资讯网是公司指定的信息披露媒体，目前公司无应披露而未披露的重大信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220170331988c179b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220170331988c179b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","00719","01477","BK1191","BK1515"],"gpt_icon":0},{"id":"2510885001","title":"新华制药：公司始终坚持走源头减排工程治理之路","url":"https://stock-news.laohu8.com/highlight/detail?id=2510885001","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510885001?lang=zh_cn&edition=full","pubTime":"2025-02-10 11:33","pubTimestamp":1739158391,"startTime":"0","endTime":"0","summary":"有投资者向新华制药提问， 尊敬的公司领导，您好！我是一名普通公民，非常关心城市的空气质量。请问在日常的生产经营过程中，贵公司是否实施了有效的措施来减少对空气的污染？美好的生活环境需要大家共同守护，希望贵公司能在这方面发挥积极作用公司回答表示，正如您所愿，美好的生活环境需要大家共同守护。公司始终坚持走源头减排、工程治理、绿色低碳、循环经济发展之路。坚持多措并举、守正创新，全面提升公司环保管理绩效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210114542a23ff103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210114542a23ff103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00719","BK1191","BK1515"],"gpt_icon":0},{"id":"2508192416","title":"智通AH统计|2月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2508192416","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508192416?lang=zh_cn&edition=full","pubTime":"2025-02-03 16:15","pubTimestamp":1738570505,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止2月3日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为958.82%、365.42%、343.92%；招商银行、美的集团、药明康德分列AH溢价率末三位，溢价率分别为16.34%、18.70%、19.37%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1245359.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","BK1607","02238","LU2249611893.SGD","01635","LU0819121731.USD","00553","06690","81211","02338","06680","00323","01349","00317","03908","02218","01033","02359","03606","159982","03328","01072","03968","SG9999006514.SGD","00568","01138","LU0228367735.SGD","03678","SGXZ49509284.SGD","002594","03143","00763","00300","01057","688981","00719","00916","BK1594","02208","00042","HYDD.SI","BK1221","00187","01988","02899","BYDDY","LU2125910500.SGD","01211"],"gpt_icon":1},{"id":"2507402612","title":"智通AH统计|1月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=2507402612","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507402612?lang=zh_cn&edition=full","pubTime":"2025-01-30 16:15","pubTimestamp":1738224905,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止1月30日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为938.46%、362.29%、328.79%；招商银行、美的集团、药明康德分列AH溢价率末三位，溢价率分别为14.16%、18.14%、20.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1245088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02208","02359","02899","81211","06198","BK1582","06066","02611","BK1594","HYDD.SI","06690","00300","00317","01349","002594","159982","00042","00187","00323","03908","06869","02238","LU0348735423.USD","06680","00568","03606","688981","01988","01211","00719","02338","LU1807302812.USD","00916","00763","00548","03328","399300","03678","01033","01057","SG9999012728.SGD","02218","03968","00553","BYDDY","LU2778985437.USD","02628","03143"],"gpt_icon":1},{"id":"2507500874","title":"智通AH统计|1月29日","url":"https://stock-news.laohu8.com/highlight/detail?id=2507500874","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507500874?lang=zh_cn&edition=full","pubTime":"2025-01-29 16:15","pubTimestamp":1738138504,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止1月29日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为938.46%、362.29%、328.79%；招商银行、美的集团、药明康德分列AH溢价率末三位，溢价率分别为14.16%、18.14%、20.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1245030.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00553","02628","06869","00187","688981","LU1048596156.SGD","00548","002594","03968","00568","BK1505","03606","01349","02611","03908","06690","81211","BYDDY","01211","SG9999012736.USD","01057","00317","06066","02218","06680","00323","03143","IE0034224299.USD","06198","02238","159982","00300","00719","03678","01033","LU0214875030.USD","HYDD.SI","02208","02899","00042","399300","02338","BK1592","00916","03328","01988","02359"],"gpt_icon":1},{"id":"2505063687","title":"智通AH统计|1月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2505063687","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505063687?lang=zh_cn&edition=full","pubTime":"2025-01-23 16:15","pubTimestamp":1737620106,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止1月23日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为938.46%、377.78%、343.82%；招商银行、美的集团、药明康德分列AH溢价率末三位，溢价率分别为15.80%、19.47%、19.96%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1242482.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00568","03908","01057","159982","00553","00956","688981","02628","00981","00895","02218","06690","81211","06680","399300","03606","LU0048580855.USD","03968","02899","01988","06869","00042","03996","BK1154","00300","01033","01211","01456","03143","02338","01766","00323","BYDDY","LU2778985437.USD","01349","02359","03678","00588","01658","HYDD.SI","00317","00916","06198","00719","00187","002594","03369","IE00BPRC5H50.USD"],"gpt_icon":1},{"id":"2505886246","title":"【港股通】山东新华制药股份恩格列净片获国家药督局注册批准 适用于治疗2型糖尿病","url":"https://stock-news.laohu8.com/highlight/detail?id=2505886246","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505886246?lang=zh_cn&edition=full","pubTime":"2025-01-21 17:19","pubTimestamp":1737451181,"startTime":"0","endTime":"0","summary":"金吾财讯 | 山东新华制药股份(00719)公布，近日公司收到国家药品监督管理局核准签发的恩格列净片(10mg)《药品注册证书》，本品符合药品注册的有关要求，批准注册。恩格列净片适用于治疗2型糖尿病；用于症状性慢性心力衰竭成人患者，降低因心力衰竭住院的风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121172353986de367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121172353986de367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","HSCEI","00719","BK1191","HSTECH"],"gpt_icon":0},{"id":"2505924852","title":"山东新华制药股份：恩格列净片(10mg)取得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2505924852","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505924852?lang=zh_cn&edition=full","pubTime":"2025-01-21 16:34","pubTimestamp":1737448484,"startTime":"0","endTime":"0","summary":"格隆汇1月21日丨山东新华制药股份公布，近日，公司收到国家药品监督管理局核准签发的恩格列净片《药品注册证书》，本品符合药品注册的有关要求，批准注册。2023年6月，新华制药向国家药品监督管理局药品审评中心递交恩格列净片上市许可注册申报资料并获受理，2025年1月获得《药品注册证书》，审评结论为批准注册。恩格列净片适用于治疗2型糖尿病；用于症状性慢性心力衰竭成人患者，降低因心力衰竭住院的风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121163444abb2e07d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121163444abb2e07d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","00719"],"gpt_icon":0},{"id":"2505210653","title":"山东新华制药股份(00719)收到瑞舒伐他汀钙片(20mg;10mg)《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2505210653","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505210653?lang=zh_cn&edition=full","pubTime":"2025-01-21 16:31","pubTimestamp":1737448302,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)公布，近日，公司收到国家药品监督管理局核准签发的瑞舒伐他汀钙片(20mg;10mg)《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。瑞舒伐他汀钙片(20mg;10mg)于2025年1月通过国家药品监督管理局审批，新华制药成为本品的上市许可持有人。该产品的上市，有利于丰富公司血脂调节剂他汀类药物产品线，提升公司综合竞争优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1241032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)收到瑞舒伐他汀钙片(20mg;10mg)《药品补充申请批准通知书》","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","00719","BK1191"],"gpt_icon":0},{"id":"2504476145","title":"山东新华制药股份(00719)获得盐酸左沙丁胺醇雾化吸入溶液《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2504476145","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504476145?lang=zh_cn&edition=full","pubTime":"2025-01-20 17:01","pubTimestamp":1737363693,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，公司收到国家药品监督管理局核准签发的盐酸左沙丁胺醇雾化吸入溶液《药品补充申请批准通知书》，该产品上市许可持有人转让申请获得批准。盐酸左沙丁胺醇雾化吸入溶液用于治疗或预防成人及6岁以上儿童可逆性气道阻塞性疾病引起的支气管痉挛。盐酸左沙丁胺醇雾化吸入溶液于2025年1月通过国家药品监督管理局审批，新华制药成为本品的上市许可持有人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)获得盐酸左沙丁胺醇雾化吸入溶液《药品补充申请批准通知书》","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719","BK1515","BK1191"],"gpt_icon":0},{"id":"2503352965","title":"鲁抗医药：公司未接到与新华制药重组的相关通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2503352965","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503352965?lang=zh_cn&edition=full","pubTime":"2025-01-16 16:45","pubTimestamp":1737017109,"startTime":"0","endTime":"0","summary":"金融界1月16日消息，有投资者在互动平台向鲁抗医药提问：董秘你好，公司跟新华制药大股东都是山东国资委，是否考虑跟新华制药重组，做大做强。公司回答表示：公司目前未接到与新华制药重组的相关通知。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116165620abacf606&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116165620abacf606&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00719","BK1515"],"gpt_icon":0},{"id":"2503954115","title":"山东新华制药股份(00719)注销25.74万份股票期权","url":"https://stock-news.laohu8.com/highlight/detail?id=2503954115","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503954115?lang=zh_cn&edition=full","pubTime":"2025-01-16 16:35","pubTimestamp":1737016525,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，由于公司2021年A股股票期权激励计划首次授予激励对象中2人因岗位调整，1人因个人原因离职，1人因达到退休年龄退休，根据公司《2021年A股股票期权激励计划(草案)》的规定，上述人员已不具备激励对象资格，公司对其已获授但未行权的25.74万份股票期权予以注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1238635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719","BK1515","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xhzy.com","stockEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":-0.0414},{"period":"3month","weight":-0.0018},{"period":"6month","weight":-0.081},{"period":"1year","weight":0.1151},{"period":"ytd","weight":-0.043}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0898},{"period":"3month","weight":0.0902},{"period":"6month","weight":0.0524},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.0749}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东新华制药股份有限公司是一家主要从事化学原料药、制剂和医药中间体的开发、制造和销售的中国公司。该公司的产品主要包括安乃近、咖啡因、氨基比林、阿斯匹林、氢化可的松、吡哌酸、布洛芬、左旋多巴、吡哌酸片、复方甘草片和尼莫地平片等。该公司的产品销往中国国内与海外市场，包括美洲和欧洲等。","yearOnYearQuotes":[{"month":1,"riseRate":0.586207,"avgChangeRate":-0.015008},{"month":2,"riseRate":0.793103,"avgChangeRate":0.103834},{"month":3,"riseRate":0.448276,"avgChangeRate":-0.005218},{"month":4,"riseRate":0.724138,"avgChangeRate":0.105748},{"month":5,"riseRate":0.321429,"avgChangeRate":-0.003589},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.006604},{"month":7,"riseRate":0.571429,"avgChangeRate":0.006209},{"month":8,"riseRate":0.296296,"avgChangeRate":-0.041364},{"month":9,"riseRate":0.37037,"avgChangeRate":-0.017083},{"month":10,"riseRate":0.464286,"avgChangeRate":0.010896},{"month":11,"riseRate":0.535714,"avgChangeRate":0.01142},{"month":12,"riseRate":0.607143,"avgChangeRate":0.027551}],"exchange":"SEHK","name":"山东新华制药股份","nameEN":"SHANDONG XINHUA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"山东新华制药股份(00719)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供山东新华制药股份(00719)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"山东新华制药股份,00719,山东新华制药股份股票,山东新华制药股份股票老虎,山东新华制药股份股票老虎国际,山东新华制药股份行情,山东新华制药股份股票行情,山东新华制药股份股价,山东新华制药股份股市,山东新华制药股份股票价格,山东新华制药股份股票交易,山东新华制药股份股票购买,山东新华制药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"山东新华制药股份(00719)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供山东新华制药股份(00719)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}